The faculty members are mainly responsible for drawing up all the theoretical contents of the Master’s Programme.

 

Mr. Alexander Adan
Citometry Applications Specialist. Miltenyi Biotec. Madrid.

Dr. Elisabet Aguilar
Process Improvement Manager. Andalusian Network for the design and translation of Advanced Therapies. Sevilla.

Prof. Miguel Alaminos
Professor. Department of Histology. Faculty of Medicine. University of Granada. Granada.

Dr. Antonia Álvarez
Technical Advisor. Andalusian Transplant Coordination. Andalusian Health Service. Sevilla.

Dr. Salvador Arias-Santiago
Qualified Person. Cell Production and Tissue Engineering Unit. Head of Dermatology. Hospital Universitario Virgen de las Nieves de Granada. Professor. Department of Histology. Faculty of Medicine. University of Granada. Granada.

Ms. Blanca Arribas
GMP Quality Manager. Production and Reprogramming Cell Unit of Sevilla. Sevilla.

Dr. Pedro Baptista
Group Leader. Laboratory of Organ Bioengineering and Regenerative Medicine, GI and Hepatology Research Group - IIS Aragón. Visiting Professor. Biomedical Engineering Department, Carlos III of Madrid University, Madrid. Secretary General of the European Society of Artificial Organs (ESAO). Chairman of the EASL Consortium for Regenerative Hepatology. Genève.

Dr. Karim Benabdellah
Senior Scientist. Gene and Cell Therapy Research Group. Pfizer – University of Granada- Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Granada.

 

Dr. Rafael Campos

Specialist Technician in Preclinical Regulatory of Advanced Therapies. Andalusian Network for the Design and Translation of Advanced Therapies. Sevilla

Prof. Antonio Campos
Emeritus Professor. Department of Histology. Faculty of Medicine. University of Granada. Granada.

Dr. Fernando Campos
Professor. Department of Histology. Faculty of Medicine. University of Granada. Granada.

Dr. Gloria Carmona
Coordinator of the Andalusian Network for the design and translation of Advanced Therapies. Andalusian Network for the design and translation of Advanced Therapies. Sevilla. Qualified Person. Production and Reprogramming Cell Unit. Sevilla.

 

Dr. Victor Sebastián Carriel
Professor. Department of Histology. Faculty of Medicine. University of Granada. Granada.

 

Mr. Jesús Chaparro
QA/QC Manager. IBIMA. Málaga.

Dr. Jesús Chato
Assistant Professor. Department of Histology. University of Granada. Granada.

 

Dr. Begoña Díez Cabezas

Biomedical Innovation Unit. CIEMAT. Madrid.

 

Dr. Massimo Dominici
Head of the Laboratory of Cell Biology and Advanced Cancer Therapies. University Hospital of Modena and Reggio Emilia. Italy. Former Chair. ISCT Presidential Task Force on the Use of Unproven Cellular Therapies. Vancouver.

 

Dr. Ana Fernández González
Manufacturing Manager. Cell Production and Tissue Engineering Unit. Hospital Universitario Virgen de las Nieves. Granada

Dr. Daniela Ferrari
Adjunct Professor and Research Fellow. Department of Biotechnology and Biosciences. University of Milan-Bicocca. Milan. 

 

Dr. Ana Belén García Delgado
Margarita Salas Post-Doctoral Researcher. Pharmacy Department. University of Sevilla. Specialist Laboratory Technician. Production and Reprogramming Cell Unit. LARCEL. Sevilla

 

Dr. Óscar García
Assistant Professor. Department of Histology. University of Granada. Granada.

Prof. Ingrid J. Garzón
Professor. Department of Histology. University of Granada. Granada.

Dr. María Elena González Muñoz
Group Leader. Nanobiotechnology Area. Bionand. Málaga. Professor. Cell biology, Phisiology and Genetics Department. University of Malaga. Málaga.

 

Dr. África González Murillo

Advanced Therapies Unit. Fundación para la Investigación Biomédica. Hospital Infantil Universitario del Niño Jesús. Madrid

Dr. Manuel Juan Otero
Head of Immunotherapy Section. Immunology Service. Hospital Clinic. Barcelona. Director of Immunotherapy Platform. Hospital Sant Joan de Déu, Hospital Clinic. Barcelona.

Dr. Manuel Jesús López Baroni
Professor of Public Law. Pablo de Olavide University. Sevilla.

 

Mr. Luis López Navas

Regulatory Consultant. DLRC Regulatory Consultancy. London.

Dr. María del Mar Macías
Pharmacovigilance Specialist Technician. Andalusian Network for the design and translation of Advanced Therapies. Sevilla.

Dr. María Martín López

Manufacturing Specialist Technician. Production and Reprogramming Cell Unit. Andalusian Network for the design and translation of Advanced Therapies. Sevilla.

 

Dr. Miguel Ángel Martín Piedra
Professor. Department of Histology. Faculty of Medicine. University of Granada. Granada.

 

Dr. Francisco Javier Molina 
Senior Postdoctoral Researcher. Gene and Cell Therapy Research Group. Pfizer – University of Granada - Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Granada.

Prof. Ramón Muñoz- Chápuli
Professor. Department of Animal Biology. University of Malaga. Málaga. Director. Doctoral School. University of Malaga. Málaga.

 

Dr. Pilar Muñoz Fernández
Postdoctoral scientist. Gene and Cell Therapy Research Group. Pfizer – University of Granada - Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Granada.

Dr. Daniela Celeste Profico
Senior Cell and Gene Therapy Consultant. Propharma Group. Italy

 

Ms. Blanca Quijano 
Clinical Trial Coordinator. Andalusian Network for the design and translation of Advanced Therapies. Sevilla.

 
Dr. Antonio Rodríguez Acosta
Qualified Person. Cell Production Unit. Hospital Regional de Málaga. Málaga

 

Dr. David Sánchez Porras
Research Assistant. Department of Histology. University of Granada. Granada.

 

Dr. Natalia  Sánchez Romero 
R&D Director at BeCytes Biotechnologies. Barcelona. Associate Researcher. Laboratory of Organ Bioengineering and Regenerative Medicine, GI and Hepatology Research Group - IIS Aragón. Visiting Professor. San Jorge University. Zaragoza

  

Dr. Mónica Santos

Head of Production. Transfusion Centre of Cell and Tissue. Production and Reprogramming Cell Unit. Sevilla.

 

Dr. María Tristán Manzano

Gene and Cell Therapy Research Group. Pfizer – University of Granada - Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Granada.

Dr. Joaquím Vives
Director of Research and Development Department. Blood and Tissue Bank. Xcelia. Barcelona.